| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |